AHR and chronic kidney disease: By activating the AhR pathway, IAA induces endothelial oxidative stress and inflammation by increasing ROS and expression of COX‐2 and tissue factor via activating the AhR/p38MAPK/NF‐KB pathway, which contributes to the high CV risk of patients with CKD [47, 52].